U.S. pauses new patients on Merck MS drug in blow to shares

Indonesia Berita Berita

U.S. pauses new patients on Merck MS drug in blow to shares
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

Merck KGaA said on Wednesday the U.S. Food and Drug Administration (FDA) had paused the initiation of new patients on its multiple sclerosis evobrutinib drug, knocking the German drugmaker's share price.

said on Wednesday the U.S. Food and Drug Administration had paused the initiation of new patients on its multiple sclerosis evobrutinib drug, knocking the German drugmaker's share price.

Merck shares were 6.3% lower at 1037 GMT and slid to the bottom of Germany's blue-chip DAX index on news of the setback. "Merck is working closely with the FDA to establish the best path forward for the benefit of patients in current and future trials with evobrutinib," it said in a statement.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Double whammy: Rising gas, food prices hit local food trucksDouble whammy: Rising gas, food prices hit local food trucks“We try to be conscious about it, but also on the other hand, we have to make sure that we survive and make a little bit of money, you know?” Julio Gonzalez, the owner of Jammas Jax, told News4JAX.
Baca lebih lajut »

Demand at regional food banks soars as layoffs, food prices, increaseDemand at regional food banks soars as layoffs, food prices, increaseThe primary food bank which serves San Mateo and Santa Clara counties is seeing rising demand only slightly below pandemic-era highs. Higher food prices and layoffs are citied. Leaders say more support is needed from cities and the private sector.
Baca lebih lajut »

Merck, Eisai to Discontinue Late-Stage Study for Skin CancerMerck, Eisai to Discontinue Late-Stage Study for Skin CancerMerck & Co Inc and Eisai Co Ltd said they were discontinuing a late-stage study of Keytruda plus Lenvima for the treatment of adults with unresectable or metastatic melanoma, as the trial did not show improvement in overall survival.
Baca lebih lajut »

Newark school board candidates forum set for Wednesday, ahead of April 25 electionNewark school board candidates forum set for Wednesday, ahead of April 25 electionThe virtual forum at 6 p.m. on April 14 is intended to educate voters and improve last year's low 3% turnout
Baca lebih lajut »

Mainly Dry And Trending Warmer Through Wednesday - Alabama NewsMainly Dry And Trending Warmer Through Wednesday - Alabama NewsThe sky remains partly to mostly cloudy across our area on average Monday afternoon. Monday afternoon remains breezy with an east-northeast wind of 10 to 15 mph. Temperatures likely remain cool, with highs in the upper 60s to low 70s.
Baca lebih lajut »



Render Time: 2025-03-04 04:31:25